Stand out for this role — generate a tailored resume and cover letter in about a minute.
Vaxxinova US is seeking a Senior Accountant for an onsite, full-time role in Willmar, MN. You will support accounting operations, ensure accuracy of financial reporting, and collaborate across departments.
The position involves leading close processes, reconciliations, budgeting support, and audits, with opportunities for growth in a supportive environment.
If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.
Full Time Willmar, MN, US
30+ days ago Requisition ID: 1188
Salary: $80,000.00 Annually
Vaxxinova US is seeking an individual to join our finance team as a Senior Accountant. This role is an onsite, office-based position located in Willmar, MN.
At Vaxxinova US, you'll be part of a passionate team dedicated to making a difference. We offer competitive pay and benefits, opportunities for growth, and a supportive work culture.
About the role: The Senior Accountant is responsible for supporting the company's accounting and financial operations by performing advanced accounting functions, overseeing key financial processes, and ensuring the accuracy and integrity of financial reporting. This position works collaboratively across departments to ensure timely and reliable financial information while supporting operational and business objectives.
Main Responsibilities:
Qualifications and Capabilities:
Experience/Educational Requirements:
Benefits at Vaxxinova:
We are proud to offer a generous benefit package in addition to competitive compensation, including employer contributions towards medical, dental and vision premiums. Most benefits begin on date of hire. Our benefits include:
About Vaxxinova
Vaxxinova provides a wide range of both autogenous and licensed vaccines combined with high-level diagnostic services, supported by strong R&D. Our focus is on livestock including cattle, poultry, swine and aqua. Vaxxinova US, formerly known as Epitopix and Newport Laboratories, is the US operating unit of Vaxxinova International, headquartered in the Netherlands. Vaxxinova US has a strong market presence making autogenous vaccines for cattle, swine, and poultry as well as a state-of-the-art diagnostic laboratory. Vaxxinova currently has facilities in fourteen countries including Brazil, Canada, Chile, Colombia, Croatia, Italy, Germany, Japan, Jordan, Norway, South Africa, Thailand, the USA, and the Netherlands. Vaxxinova is part of the family-owned EW Group, headquartered in Germany. The EW Group specializes in animal genetics, animal nutrition and animal health, operates in over 100 countries and records consistent international growth.